General considerations for the clinical evaluation of drugs in infants and children

LDR 01544nam a22003611i 4500
001 000090625
003 MiAaHDL
005 20250106000000.0
006 m d
007 cr bn ---auaua
008 880715s1977 mdu f000 0 eng d
020 ‡q(pbk.) ‡c$1.10
035 ‡a(MiU)990000906250106381
035 ‡asdr-miu.990000906250106381
035 ‡asdr-umn002956200
035 ‡z(MiU)MIU01000000000000000090625-goog
035 ‡a(CaOTULAS)160063912
035 ‡a(RLIN)MIUG3580744-B
035 ‡a(OCoLC)14381548
035 ‡a(OCoLC)3580744
035 ‡z(MiU)Aleph000090625
037 ‡a017-012-00246-3
040 ‡aDGPO ‡cDGPO ‡dCLU ‡dViRCU ‡dISUM ‡dMiU ‡dCStRLIN ‡dUtOrBLW
110 1 ‡aUnited States. ‡bFood and Drug Administration. Bureau of Drugs.
245 1 0 ‡aGeneral considerations for the clinical evaluation of drugs in infants and children.
260 ‡aRockville, Md. : ‡bDept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ; ‡aWashington : ‡bfor sale by the Supt. of Docs., U.S. Govt. Print. Off., ‡c1977.
300 ‡aiii, 20 p. ; ‡c27 cm.
336 ‡atext ‡btxt ‡2rdacontent
337 ‡aunmediated ‡bn ‡2rdamedia
338 ‡avolume ‡bnc ‡2rdacarrier
490 0 ‡aDHEW publication ; no. (FDA) 77-3041
490 0 ‡aFDA Bureau of Drugs clinical guidelines
500 ‡aIssued Sept. 1977.
538 ‡aMode of access: Internet.
650 0 ‡aDrugs ‡xTesting. ‡0http://id.loc.gov/authorities/subjects/sh85039755
650 2 ‡aDrug Therapy ‡xin infancy & childhood.
650 2 ‡aDrug Evaluation. ‡0http://id.nlm.nih.gov/mesh/D004341
650 2 ‡aDrug Evaluation ‡xin infancy & childhood.
899 ‡a39015003205070
CID ‡a000090625
DAT 0 ‡a20241218074108.0 ‡b20250106000000.0
DAT 1 ‡a20250108033013.0 ‡b2025-01-08T20:27:07Z
DAT 2 ‡a2023-08-04T17:30:03Z
CAT ‡aSDR-MIU ‡cmiu ‡dALMA ‡lprepare.pl-004-009
FMT ‡aBK
HOL ‡0sdr-miu.990000906250106381 ‡aMiU ‡bSDR ‡cMIU ‡f000090625 ‡pmdp.39015003205070 ‡sMIU ‡1990000906250106381
974 ‡bMIU ‡cMIU ‡d20250108 ‡sgoogle ‡umdp.39015003205070 ‡y1977 ‡rpd ‡qbib ‡tUS fed doc
974 ‡bUMN ‡cUMN ‡d20250104 ‡sgoogle ‡uumn.31951003051182m ‡y1977 ‡rpd ‡qbib ‡tUS fed doc